Loctek(SZ:300729) Zheng Quan Zhi Xing·2025-05-19 09:54Group 1 - The legal opinion letter is issued by Grandall Law Firm (Shanghai) regarding the adjustment of the grant price for the 2021 restricted stock incentive plan of Lekai Ergonomics Technology Co., Ltd. [1][2] - The adjustment of the grant price is based on the company's compliance with relevant laws, regulations, and its own articles of association [2][11] - The company has obtained necessary approvals from the board of directors, supervisory board, and shareholders' meeting for the incentive plan [6][9] Group 2 - The grant price for the restricted stock has been adjusted from 11.06 yuan per share to 8.24 yuan per share due to the implementation of the 2022 annual equity distribution plan [7][9] - The adjustment method for the grant price follows the provisions of the incentive plan, which includes considerations for cash dividends and other corporate actions [10][11] - The company is required to fulfill its information disclosure obligations as per relevant laws and regulations following the adjustment [12]